Safety and Immunogenicity of the Heterologous 2-Dose Ad26.ZEBOV, MVA-BN-Filo Vaccine Regimen in Health Care Providers and Frontliners of the Democratic Republic of the Congo.
Larivière Y, Garcia-Fogeda I, Zola Matuvanga T, Isekah Osang'ir B, Milolo S, Meta R, Kimbulu P, Robinson C, Katwere M, McLean C, Hens N, Matangila J, Maketa V, Mitashi P, Muhindo-Mavoko H, Van Geertruyden JP, Van Damme P.
Larivière Y, et al. Among authors: mitashi p.
J Infect Dis. 2024 Apr 12;229(4):1068-1076. doi: 10.1093/infdis/jiad350.
J Infect Dis. 2024.
PMID: 37673423
Free PMC article.
Clinical Trial.